Song J, Xu Z, Xie L, Shen J
Pharmaceutics. 2025; 17(2).
PMID: 40006623
PMC: 11858820.
DOI: 10.3390/pharmaceutics17020256.
Dedeloudi A, Siamidi A, Pavlou P, Vlachou M
Materials (Basel). 2022; 15(1).
PMID: 35009472
PMC: 8745980.
DOI: 10.3390/ma15010327.
Tosca E, Rocchetti M, Perez E, Nieto C, Bettica P, Del Prado J
Pharmaceutics. 2021; 13(2).
PMID: 33673306
PMC: 7918143.
DOI: 10.3390/pharmaceutics13020255.
Wang J, Wang Y, Wang Z, Wang F, He J, Yang X
Drug Deliv. 2019; 26(1):168-178.
PMID: 30822166
PMC: 6407577.
DOI: 10.1080/10717544.2019.1568622.
Aboud H, Hassan A, Ali A, Abdel-Razik A
Drug Deliv. 2018; 25(1):1328-1339.
PMID: 29869515
PMC: 6058503.
DOI: 10.1080/10717544.2018.1477858.
Degradable bioadhesive nanoparticles for prolonged intravaginal delivery and retention of elvitegravir.
Mohideen M, Quijano E, Song E, Deng Y, Panse G, Zhang W
Biomaterials. 2017; 144:144-154.
PMID: 28829952
PMC: 5581224.
DOI: 10.1016/j.biomaterials.2017.08.029.
Strategies for Prevention and Treatment of Trichomonas vaginalis Infections.
Bouchemal K, Bories C, Loiseau P
Clin Microbiol Rev. 2017; 30(3):811-825.
PMID: 28539504
PMC: 5475227.
DOI: 10.1128/CMR.00109-16.
Development and characterization of polymer-coated liposomes for vaginal delivery of sildenafil citrate.
Refai H, Hassan D, Abdelmonem R
Drug Deliv. 2017; 24(1):278-288.
PMID: 28165805
PMC: 8241125.
DOI: 10.1080/10717544.2016.1247925.
Intravaginal rings: controlled release systems for contraception and prevention of transmission of sexually transmitted infections.
Friend D
Drug Deliv Transl Res. 2015; 1(3):185-93.
PMID: 25788239
DOI: 10.1007/s13346-011-0024-4.
Advances in vaginal drug delivery.
Friend D
Drug Deliv Transl Res. 2015; 1(3):183-4.
PMID: 25788238
DOI: 10.1007/s13346-011-0030-6.
Development of a UC781 releasing polyethylene vinyl acetate vaginal ring.
McConville C, Major I, Friend D, Clark M, Malcolm R
Drug Deliv Transl Res. 2015; 2(6):489-97.
PMID: 25787327
DOI: 10.1007/s13346-012-0101-3.
Protein and oligonucleotide delivery systems for vaginal microbicides against viral STIs.
Steinbach J
Cell Mol Life Sci. 2014; 72(3):469-503.
PMID: 25323132
PMC: 11113570.
DOI: 10.1007/s00018-014-1756-3.
Accidental death via intravaginal absorption of methamphetamine.
Jones P, Mutsvunguma R, Prahlow J
Forensic Sci Med Pathol. 2014; 10(2):234-8.
PMID: 24515580
DOI: 10.1007/s12024-014-9538-7.
The vagina as a route for drug delivery: a review.
Srikrishna S, Cardozo L
Int Urogynecol J. 2012; 24(4):537-43.
PMID: 23229421
DOI: 10.1007/s00192-012-2009-3.
A 90-day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxis.
Johnson T, Clark M, Albright T, Nebeker J, Tuitupou A, Clark J
Antimicrob Agents Chemother. 2012; 56(12):6272-83.
PMID: 23006751
PMC: 3497207.
DOI: 10.1128/AAC.01431-12.
Saquinavir inhibits early events associated with establishment of HIV-1 infection: potential role for protease inhibitors in prevention.
Stefanidou M, Herrera C, Armanasco N, Shattock R
Antimicrob Agents Chemother. 2012; 56(8):4381-90.
PMID: 22664974
PMC: 3421585.
DOI: 10.1128/AAC.00399-12.
The importance of the vaginal delivery route for antiretrovirals in HIV prevention.
Ferguson L, Rohan L
Ther Deliv. 2012; 2(12):1535-50.
PMID: 22468220
PMC: 3314337.
DOI: 10.4155/tde.11.126.
Inhibition of Japanese encephalitis virus infection by the sulfated polysaccharide extracts from Ulva lactuca.
Chiu Y, Chan Y, Li T, Wu C
Mar Biotechnol (NY). 2011; 14(4):468-78.
PMID: 22193590
DOI: 10.1007/s10126-011-9428-x.
In vivo distribution of surface-modified PLGA nanoparticles following intravaginal delivery.
Cu Y, Booth C, Saltzman W
J Control Release. 2011; 156(2):258-64.
PMID: 21763739
PMC: 3220785.
DOI: 10.1016/j.jconrel.2011.06.036.
Vaginal microbicide gel for delivery of IQP-0528, a pyrimidinedione analog with a dual mechanism of action against HIV-1.
Mahalingam A, Simmons A, Ugaonkar S, Watson K, Dezzutti C, Rohan L
Antimicrob Agents Chemother. 2011; 55(4):1650-60.
PMID: 21245437
PMC: 3067148.
DOI: 10.1128/AAC.01368-10.